Cost-effective provision of cardiac services in a fixed-dollar environment

G Cohen1, J Ivanov, R D Weisel

  • 1Department of Cardiovascular Surgery, Toronto Hospital, Ontario, Canada.

Insights

Canadian hospitals manage cardiac surgery costs and patient wait times through annual government negotiations and a computerized urgency-rated waiting list. Delays occur, influenced by clinical factors, not patient demographics, but do not impact outcomes.

Area of Science:

  • Health Services Research
  • Cardiovascular Surgery
  • Health Economics

Background:

  • Canadian hospitals operate under a single-payer system with annual government negotiations for all payments, including cardiac surgery.
  • Hospitals must adhere to negotiated surgical targets, with physicians paid capitated fees and subject to penalties for exceeding targets.

Purpose of the Study:

  • To analyze the management of cardiac surgery costs and patient waiting lists within Canada's single-payer, managed care system.
  • To provide insights for US healthcare providers facing capitation and managed care models.

Main Methods:

  • Review of Canada's 30-year experience with managed cardiac care.
  • Analysis of factors influencing patient waiting times for cardiac operations.
  • Examination of cost negotiation and waiting list management strategies.

Main Results:

  • Waiting times for cardiac surgery are influenced by clinical urgency and disease factors (e.g., multiple risk factors, vessel disease, angina stability), not by patient demographics (age, sex) or reoperative status.
  • Significant delays are experienced by patients on the waiting list, exceeding target times.
  • Waiting time did not demonstrate an impact on operative mortality, postoperative low-output syndrome, or hospital length of stay.

Conclusions:

  • Canada's managed care approach to cardiac services offers valuable lessons for US healthcare systems.
  • Effective management of hospital costs through negotiation and efficient handling of patient waiting lists are critical components of managed cardiac care.

Related Concept Videos

Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...